Healing Peptide Comparison Guide: BPC-157, TB-500, GHK-Cu, KPV
Published: 2026-08-03 · Last updated: 2026-08-03
The "healing peptide" category is a loose grouping of research compounds studied in tissue repair, wound healing, and inflammation research literature. This guide compares the four most-requested ones in the Canadian market — BPC-157, TB-500, GHK-Cu, and KPV — in plain English. Nothing here is dosing advice or a clinical recommendation. This is about sourcing, availability, and what to know before ordering.
What are the four compounds and how do they differ?
BPC-157 is a synthetic pentadecapeptide (fifteen amino acids) derived from a protein found in gastric juice. It has a large body of preclinical research literature focused on gastrointestinal, musculoskeletal, and tissue-repair models. It is one of the most-studied research peptides in this category by publication volume.
TB-500 is a synthetic fragment of thymosin beta-4, a naturally occurring peptide involved in actin regulation and cell migration. Research literature covers tissue repair, angiogenesis, and inflammation modulation. It is often studied alongside BPC-157 because the two compounds address related but distinct pathways.
GHK-Cu is a copper-bound tripeptide (glycyl-histidyl-lysine complexed with copper) with a long research history in wound healing, skin research, and hair-follicle biology. The copper is integral to the molecule, not a contaminant. KPV is a small tripeptide fragment of alpha-MSH studied primarily in inflammation and gut research.
Why do BPC-157 and TB-500 get discussed together so often?
Research literature and the peptide research community often study or reference the two together because their proposed mechanisms are complementary. BPC-157 is often discussed in the context of tissue repair pathways; TB-500 in the context of cell migration and angiogenesis. Different pathways, overlapping research questions.
This shows up in the market as: most Canadian research peptide vendors stock the two side by side, in similar vial sizes, at broadly comparable per-mg pricing. Some vendors offer pre-mixed research blends of the two, similar to how CJC-1295 + ipamorelin gets pre-blended in the growth-hormone space.
Whether the two are actually used in combination is a separate question we do not have a view on. What we do have a view on is that both are stable, well-characterised research peptides with reliable Canadian sourcing, and both are reasonable candidates for a first-time buyer to work with.
What is special about GHK-Cu handling?
The copper complex changes the handling profile in a few ways. First, light sensitivity — GHK-Cu prefers amber vials or explicit light-protected storage. Direct UV exposure over time can affect the copper coordination. Keep the vial in its box in the fridge, and do not leave a reconstituted vial on a sunny bench.
Second, pH sensitivity — the copper-peptide complex is stable in a specific pH range and can dissociate at pH extremes. This is not something you normally have to worry about because bacteriostatic water sits comfortably in the compatible range, but it does mean you should not experiment with alternative solvents casually.
Third, appearance — reconstituted GHK-Cu is often visibly blue-tinted because of the copper. This is normal and expected. A colourless GHK-Cu solution is not necessarily wrong (concentration and specific salt form affect visibility), but if you were expecting the blue tint and it is missing, worth flagging with the vendor. Our storage guide covers the general principles.
Where does KPV fit in the Canadian market?
KPV is a smaller-audience research peptide. The publication base is narrower than for BPC-157 or TB-500, focused mainly on gut inflammation and specific inflammatory pathway research. It is a legitimate research compound with real literature behind it — just less volume.
Availability in Canada reflects the demand. Some Canadian vendors stock it consistently; others carry it only intermittently or by special order. Pricing per mg tends to be comparable to BPC-157 (both are relatively simple to manufacture), but batch sizes are smaller so you occasionally see supply gaps.
If your research specifically calls for KPV, worth checking availability at multiple Canadian vendors before committing to a research plan around it. The peptides catalogue shows our current inventory; if we do not have it, we can often point you at a Canadian competitor who does.
How does pricing compare across the four?
BPC-157 is one of the cheapest research peptides on the market per mg. Manufacturing is well-established, demand is high, and competition is intense. TB-500 is more expensive than BPC-157 but still moderate — it is a bigger peptide (about 44 amino acids), which raises raw material cost.
GHK-Cu is inexpensive per mg but usually sold in smaller vial sizes because typical research volumes are lower. You end up paying less absolute dollars per vial but the per-mg price may look surprisingly competitive when you check. KPV pricing varies more because of the smaller market — it can be a good deal at one vendor and expensive at another.
The vial strengths guide covers how per-mg pricing scales within a single compound. That pattern applies here — bigger vials cheaper per mg — but the effect is smaller for cheap-to-make peptides like BPC-157 than for expensive ones.
Which should a first-time buyer start with?
BPC-157, usually. Cheapest, most stable, most widely stocked, most-studied, and the most forgiving of any handling mistakes you make while you are learning. If you get the reconstitution wrong or leave a vial out too long, BPC-157 is more likely to still be usable than the more fragile options.
TB-500 is a fine second peptide to add once you have BPC-157 workflow down. GHK-Cu is worth exploring once you have the light-sensitivity handling right. KPV is a specialty choice — only pick it up first if your specific research plan requires it.
Whichever you start with, apply the standard first-time buyer discipline from the checklist: buy small, verify the CoA against the vial batch, test the vendor before committing to bigger orders. Reconstitution walkthrough is in the reconstitution guide.
Questions Canadian buyers ask
Are BPC-157 and TB-500 really often used together?
In published research literature and in the research peptide market, they are frequently studied and stocked together because the mechanisms are complementary. That is a description of the research landscape, not a dosing recommendation. What actual users do with them is a separate question we do not weigh in on.
Is GHK-Cu the same thing as copper peptides in cosmetics?
The molecule is the same GHK-Cu tripeptide, but concentration and formulation differ dramatically between research-grade lyophilised vials and finished cosmetic products. A skincare cream at, say, 0.05% GHK-Cu is not the same product category as a 50 mg research vial.
What is KPV and why is it less common than the others?
KPV is a smaller tripeptide fragment derived from alpha-MSH, studied in inflammation and gut research. It is less widely available than BPC-157 or TB-500 mainly because demand is smaller — the research audience is more specialised. Fewer Canadian vendors stock it.
Which is the most stable of the four?
BPC-157 is exceptionally stable, both lyophilised and in solution — one of the most forgiving research peptides on the market. TB-500 is also robust. GHK-Cu is more sensitive because of the copper complex and prefers light-protected storage. KPV is stable but you will see less handling data because there is less research volume.
Are these all Canadian-available?
BPC-157 and TB-500 are stocked at essentially every Canadian research peptide vendor. GHK-Cu is widely available but not universal. KPV is intermittent — check current inventory before planning around it.